IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY21 results · Apr–Jun 2020
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹460.11 crore (down 6.6% from Q1 FY20) and net profit of ₹127.54 crore (up 49.5% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a standalone basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 460.11 | 492.80 | −6.6% | 441.46 | +4.2% |
| Other income | 5.80 | 3.32 | +74.7% | 5.35 | +8.4% |
| Total income | 465.91 | 496.12 | −6.1% | 446.81 | +4.3% |
| Profit before tax | 146.74 | 131.02 | +12.0% | 130.08 | +12.8% |
| Net profit for the period | 127.54 | 85.32 | +49.5% | 90.26 | +41.3% |
| EPS, basic (₹) | 22.30 | 15.00 | +48.7% | 31.74 | −29.7% |
| Net margin (%) | 27.7 | 17.3 | 20.4 |
Standalone
- Filed with BSE
- 07 Aug 2020, 08:43 IST
- Board meeting
- 31 Jul 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Audited
- Source
- XBRL filing on BSE